Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERENUMAB Cause C-reactive protein increased? 135 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 135 reports of C-reactive protein increased have been filed in association with ERENUMAB (AIMOVIG). This represents 11.4% of all adverse event reports for ERENUMAB.

135
Reports of C-reactive protein increased with ERENUMAB
11.4%
of all ERENUMAB reports
134
Deaths
128
Hospitalizations

How Dangerous Is C-reactive protein increased From ERENUMAB?

Of the 135 reports, 134 (99.3%) resulted in death, 128 (94.8%) required hospitalization, and 128 (94.8%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERENUMAB. However, 135 reports have been filed with the FAERS database.

What Other Side Effects Does ERENUMAB Cause?

Off label use (293) Migraine (285) Drug ineffective (280) Gastrooesophageal reflux disease (236) Drug intolerance (227) Vomiting (220) Pain (217) Abdominal pain upper (210) Blepharospasm (209) Hypoaesthesia (204)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which ERENUMAB Alternatives Have Lower C-reactive protein increased Risk?

ERENUMAB vs ERENUMAB-AOOE ERENUMAB vs ERENUMAB\ERENUMAB-AOOE ERENUMAB vs ERGOCALCIFEROL ERENUMAB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL ERENUMAB vs ERIBULIN

Related Pages

ERENUMAB Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased ERENUMAB Demographics